Real-world effectiveness of recombinant herpes Zoster vaccine: a retrospective, cohort study in Japan
Abstract Background In Japan, a two-dose, recombinant herpes zoster vaccine (RZV) has been available since 2020, but vaccination coverage is low because vaccination is voluntary. This study investigated the real-world effectiveness of the RZV for preventing herpes zoster (HZ) by using clinical datab...
Saved in:
| Main Authors: | Satoko Ohfuji, Nozomu Toyama, Kyoko Kondo, Hisao Muto, Wakaba Fukushima |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Infectious Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11369-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024-12-01) -
The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts’ Network Scientific Workshop
by: Gyneth Lourdes G. Bibera, et al.
Published: (2024-12-01) -
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States
by: Ana Florea, et al.
Published: (2024-12-01) -
Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative NetworkResearch in context
by: Ying-Li Lin, et al.
Published: (2025-07-01) -
Current status of immunisation for herpes zoster
by: Anthony Lawrence Cunningham, et al.
Published: (2025-12-01)